N/A

CONMED Corporation, a medical technology company, released its Q4 2025 earnings call transcript, providing insight into the company's financial performance. The call took place on a recent date, although the exact date was not specified, and featured discussions from key executives, including the CEO and CFO. During the call, the company's leadership reviewed its fourth-quarter and full-year financial results, highlighting revenue growth and profitability. As of the end of 2025, CONMED Corporation reported significant increases in sales and earnings, driven by strong demand for its medical devices and equipment. The company's management attributed the success to its strategic initiatives and investments in research and development. The earnings call transcript is available for public review, offering investors and industry analysts a detailed look at CONMED's financial health and future outlook. The medical technology industry, in which CONMED operates, continues to experience growth, driven by advancements in healthcare and an aging population.